PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 19 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | – | 657 | +0.2% | 0.00% | – |
| Q4 2020 | $0 | – | 656 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 656 | -0.2% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 657 | -99.7% | 0.00% | – |
| Q4 2019 | $114,000 | -90.5% | 238,000 | -88.3% | 0.00% | -100.0% |
| Q4 2016 | $1,203,000 | +32.1% | 2,030,000 | +26.5% | 0.00% | 0.0% |
| Q3 2016 | $911,000 | – | 1,605,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 31,204,000 | $31,610,000 | 0.98% |
| Opti Capital Management, LP | 8,000,000 | $8,206,000 | 0.66% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 14,527,000 | $15,076,000 | 0.34% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 15,519,000 | $15,848,000 | 0.31% |
| CSS LLC/IL | 7,007,000 | $7,112,000 | 0.26% |
| WOLVERINE ASSET MANAGEMENT LLC | 17,479,000 | $17,762,000 | 0.17% |
| LMR Partners LLP | 9,500,000 | $9,933,000 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,672,000 | $4,858,000 | 0.11% |
| Verition Fund Management LLC | 8,091,000 | $8,233,000 | 0.10% |
| Aequim Alternative Investments LP | 2,000,000 | $2,035,000 | 0.05% |